Growth Metrics

Steris (STE) EPS (Weighted Average and Diluted) (2018 - 2025)

Steris has reported EPS (Weighted Average and Diluted) over the past 8 years, most recently at $1.96 for Q4 2025.

  • Quarterly results put EPS (Weighted Average and Diluted) at $1.96 for Q4 2025, up 12.0% from a year ago — trailing twelve months through Dec 2025 was $7.12 (up 52.79% YoY), and the annual figure for FY2025 was $6.16, up 61.68%.
  • EPS (Weighted Average and Diluted) for Q4 2025 was $1.96 at Steris, up from $1.94 in the prior quarter.
  • Over the last five years, EPS (Weighted Average and Diluted) for STE hit a ceiling of $1.96 in Q4 2025 and a floor of -$0.24 in Q2 2021.
  • Median EPS (Weighted Average and Diluted) over the past 5 years was $1.36 (2023), compared with a mean of $1.23.
  • Biggest five-year swings in EPS (Weighted Average and Diluted): tumbled 122.86% in 2021 and later surged 14400.0% in 2025.
  • Steris' EPS (Weighted Average and Diluted) stood at $1.42 in 2021, then fell by 12.68% to $1.24 in 2022, then rose by 14.52% to $1.42 in 2023, then increased by 23.24% to $1.75 in 2024, then rose by 12.0% to $1.96 in 2025.
  • The last three reported values for EPS (Weighted Average and Diluted) were $1.96 (Q4 2025), $1.94 (Q3 2025), and $1.79 (Q2 2025) per Business Quant data.